Purple Biotech vs Tharimmune
Purple Biotech vs Tharimmune, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Purple Biotech is on 20/100 and Tharimmune on 53/100.
Where each one leads
Purple Biotech
- agent readiness: 50/100 against 31/100
- headcount: 19 against 13
Tharimmune
- our overall score: 53/100 against 20/100
At a glance
| Measure | Purple Biotech | Tharimmune |
|---|---|---|
| What it is | Clinical-stage company developing novel oncology therapies to overcome tumor immune evasion and drug resistance. | Biotechnology company developing novel immunotherapies for cancer. |
| Category | Biotech, Life Sciences, Drug Discovery, Clinical Trials | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2013 | 2017 |
| Headquarters | Tel Aviv, Israel | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Purple Biotech | Tharimmune |
|---|---|---|
| Employees | 19 | 13 |
| Total funding | Not published | $540M |
| Latest round | Bootstrapped | Not published |
| LinkedIn followers | 1,430 | 1,718 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Purple Biotech | Tharimmune |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 20/100 | 53/100 |
| Traction | 13/100 | 51/100 |
| Team | Not published | 70/100 |
| Community | Not published | 15/100 |
| Search visibility | 25/100 | 22/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (31/100) |
| Domain ratingLink authority, 0-100 | 26/100 | 26/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Purple Biotech | Tharimmune |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | Webflow |
What users say
| Measure | Purple Biotech | Tharimmune |
|---|---|---|
| Reddit sentimentThreads we track | 4 positive, 0 negative across 6 threads | Not published |
“Purple Biotech presenta nuevos datos preclínicos en EACR 2026 que destacan la actividad antitumoral de IM1240, su favorable perfil de seguridad y farmacocinético, y su amplio margen terapéutico.”r/biotech_stocks
Purple Biotech vs Tharimmune: common questions
Which is better, Purple Biotech or Tharimmune?
On our 0-100 score Tharimmune rates higher (53/100 against 20/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Purple Biotech and Tharimmune compare on the numbers?
Purple Biotech leads on agent readiness (50/100 against 31/100), headcount (19 against 13). Tharimmune leads on our overall score (53/100 against 20/100).
What do real users say about Purple Biotech and Tharimmune?
Purple Biotech: 4 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/biotech_stocks.
Read the full Purple Biotech review and pricing or the Tharimmune review and pricing. You can also browse other Purple Biotech alternatives we track.